A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
NCT01393743, EU, CTR, 2011-000265-12
Primary Generalised Tonic Clonic Seizures
Phase 3
Sharing of clinical data is prevented for the following countries; Netherlands, Thailand, Czech, Poland, France, Lithuania, Korea, Serbia, Greece, China, Australia, Germany, Austria, Latvia and Hungary, due to ICF restrictions.
June 2016